AU1671883A - Carbacyclin pharmaceutical preparations - Google Patents

Carbacyclin pharmaceutical preparations

Info

Publication number
AU1671883A
AU1671883A AU16718/83A AU1671883A AU1671883A AU 1671883 A AU1671883 A AU 1671883A AU 16718/83 A AU16718/83 A AU 16718/83A AU 1671883 A AU1671883 A AU 1671883A AU 1671883 A AU1671883 A AU 1671883A
Authority
AU
Australia
Prior art keywords
group
denotes
radical
atoms
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU16718/83A
Other versions
AU571841B2 (en
Inventor
Jorge Casals-Stenzel
Bernd Raduchel
Werner Skuballa
Helmut Vorbruggen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU1671883A publication Critical patent/AU1671883A/en
Application granted granted Critical
Publication of AU571841B2 publication Critical patent/AU571841B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/005—Analogues or derivatives having the five membered ring replaced by other rings
    • C07C405/0075—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system
    • C07C405/0083—Analogues or derivatives having the five membered ring replaced by other rings having the side-chains or their analogues or derivatives attached to a condensed ring system which is only ortho or peri condensed, e.g. carbacyclins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Abstract

Carbacylin derivatives of the general formula I <IMAGE> in which R1 denotes a hydrogen atom or the radical OR2, in which R2 can denote hydrogen, alkyl, cycloalkyl, aryl, the radical <IMAGE> or a heterocyclic radical, or R1 can denote the radical NHR3 where R3 denotes an acid radical or the radical R2, n can denote the number 2, 3, 4 or 5, X denotes a hydrogen atom or a fluorine atom, A denotes a -CH2-CH2-, a trans -CH=CH- or -C IDENTICAL C- group, W denotes a free or functionally modified hydroxymethylene group or a free or functionally modified <IMAGE> group, in which the OH group can be in the alpha or beta position, D denotes the group <IMAGE> a straight-chain, saturated alkylene group having 1-5 C atoms, a branched saturated or a straight-chain or branched unsaturated alkylene group having 2-5 C atoms, which may be substituted by fluorine atoms, m can denote the number 1, 2 or 3, E represents a direct bond, a -C IDENTICAL C- group or a -CR6=CR7- group, in which R6 denotes a hydrogen atom or an alkyl group having 1-5 C atoms and R7 denotes a hydrogen atom, an alkyl group having 1-5 C atoms or a halogen atom, R4 denotes an alkyl, cycloalkyl or a substituted or unsubstituted aryl group or a heterocyclic group, R5 denotes a free or functionally modified hydroxyl group, and, if R2 denotes a hydrogen atom, the salts thereof with physiologically acceptable bases, a process for their preparation and their use as pharmaceuticals.
AU16718/83A 1982-07-13 1983-07-11 Carbacyclin pharmaceutical preparations Ceased AU571841B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3226550 1982-07-13
DE19823226550 DE3226550A1 (en) 1982-07-13 1982-07-13 NEW CARBACYCLINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS

Publications (2)

Publication Number Publication Date
AU1671883A true AU1671883A (en) 1984-01-19
AU571841B2 AU571841B2 (en) 1988-04-28

Family

ID=6168531

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16718/83A Ceased AU571841B2 (en) 1982-07-13 1983-07-11 Carbacyclin pharmaceutical preparations

Country Status (19)

Country Link
EP (1) EP0099538B1 (en)
JP (1) JPS5921636A (en)
AT (1) ATE67182T1 (en)
AU (1) AU571841B2 (en)
CA (1) CA1248525A (en)
CS (1) CS235329B2 (en)
DD (1) DD210027B3 (en)
DE (2) DE3226550A1 (en)
DK (1) DK163579C (en)
ES (1) ES524058A0 (en)
FI (1) FI77645C (en)
GR (1) GR78873B (en)
HU (1) HU191057B (en)
IE (1) IE57233B1 (en)
IL (1) IL69199A (en)
NZ (1) NZ204875A (en)
PH (1) PH25119A (en)
SU (1) SU1316555A3 (en)
ZA (1) ZA835109B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU567911B2 (en) * 1983-02-01 1987-12-10 Sumitomo Chemical Company, Limited Bicyclooctane derivatives
AU571443B2 (en) * 1982-07-02 1988-04-21 Schering Aktiengesellschaft Carbacyclin amides

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225288A1 (en) * 1982-07-02 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen NEW CARBACYCLINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
DE3405181A1 (en) * 1984-02-10 1985-08-22 Schering AG, 1000 Berlin und 4709 Bergkamen NEW CARBACYCLINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
US4971987A (en) * 1984-07-27 1990-11-20 Schering Aktiengesellschaft New carbacycline, process for their production and their use as a drug
DE3933523A1 (en) * 1989-10-05 1991-04-11 Schering Ag ANTIMETASTICALLY ACTIVE AGENTS
EP0431571A3 (en) * 1989-12-05 1992-01-02 Sagami Chemical Research Center Cis-bicyclo(4.3.0)non-2-ene derivatives
DE4104607A1 (en) * 1991-02-12 1992-08-13 Schering Ag PROSTACYCLIN AND CARBACYCLINE DERIVATIVES AS A MEDIUM FOR TREATING FEVERED DISEASES
ATE306256T1 (en) 1999-08-05 2005-10-15 Teijin Ltd AGENTS FOR IMPROVING NEUROPATHY WHICH CONTAIN NITROGEN-CONTAINING COMPOUNDS AS THE ACTIVE INGREDIENTS
EP2269611B1 (en) 2006-11-16 2016-03-23 Gemmus Pharma Inc. EP2 and EP4 agonists as agents for the treatment of influenza A viral infection
NZ599128A (en) 2009-10-14 2014-02-28 Gemmus Pharma Inc Combination therapy treatment for viral infections
CN105979959B (en) 2013-08-09 2021-11-30 阿德利克斯公司 Compounds and methods for inhibiting phosphate transport
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2038333B (en) * 1978-01-26 1982-10-06 Erba Farmitalia 12 -formyl- (20 12)octanor-9-deoxy-9 -methylene pgi derivatives
US4705806A (en) * 1978-02-13 1987-11-10 Morton Jr Douglas R Prostacyclin analogs
DE3048906A1 (en) * 1980-12-19 1982-07-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen NEW CARBACYCLINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
IE54303B1 (en) * 1981-08-19 1989-08-16 Merrell Dow France Fluorinated diaminoalkene derivatives
GR77976B (en) * 1982-03-12 1984-09-25 Schering Ag
DE3225287A1 (en) * 1982-07-02 1984-01-05 Schering AG, 1000 Berlin und 4709 Bergkamen NEW CARBACYCLINAMIDES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571443B2 (en) * 1982-07-02 1988-04-21 Schering Aktiengesellschaft Carbacyclin amides
AU567911B2 (en) * 1983-02-01 1987-12-10 Sumitomo Chemical Company, Limited Bicyclooctane derivatives

Also Published As

Publication number Publication date
DK321283A (en) 1984-01-14
ATE67182T1 (en) 1991-09-15
HU191057B (en) 1986-12-28
DK321283D0 (en) 1983-07-12
DK163579C (en) 1992-08-03
FI832557A0 (en) 1983-07-13
FI77645C (en) 1989-04-10
AU571841B2 (en) 1988-04-28
DE3382408D1 (en) 1991-10-17
DD210027A5 (en) 1984-05-30
NZ204875A (en) 1986-11-12
ES8403865A1 (en) 1984-04-16
ES524058A0 (en) 1984-04-16
IL69199A0 (en) 1983-11-30
ZA835109B (en) 1984-08-29
DD210027B3 (en) 1990-07-18
DE3226550A1 (en) 1984-01-19
DK163579B (en) 1992-03-16
CA1248525A (en) 1989-01-10
SU1316555A3 (en) 1987-06-07
IL69199A (en) 1987-08-31
FI77645B (en) 1988-12-30
PH25119A (en) 1991-02-19
IE831630L (en) 1984-01-13
CS235329B2 (en) 1985-05-15
JPS5921636A (en) 1984-02-03
EP0099538A1 (en) 1984-02-01
IE57233B1 (en) 1992-06-17
FI832557A (en) 1984-01-14
GR78873B (en) 1984-10-02
JPH0324457B2 (en) 1991-04-03
EP0099538B1 (en) 1991-09-11

Similar Documents

Publication Publication Date Title
AU571841B2 (en) Carbacyclin pharmaceutical preparations
DK132789A (en) 9-HALOGEN (Z) PROSTAGLAND INGREDIENTS, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS A MEDICINE
ES8505352A1 (en) Mercapto-imidazole derivatives, their preparation, mercapto-imidazole derivatives for the treatment of inflammatory diseases and their pharmaceutical compositions.
AU582712B2 (en) Polymerizable carbamoyloxyalkyldicarboxylic acid esters carrying hydroxyl groups, a process for their preparation and their use
HUT39461A (en) Process for producing new steroides with substituent groups containing double or triple bond at the 10 position
AU576477B2 (en) 5-fluoro-carbacyclins
EP0069049A3 (en) Delta-8,9-prostaglandin derivatives, process for their preparation and their use as medicaments
JPS52100470A (en) Synthesis of hydantoin derivatives
ATE92461T1 (en) ACTIVE AGAINST CEREBRAL INSUFFICIENCY COMPOUNDS.
DK101085D0 (en) CARBACYCLINES, THEIR PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
JPS5227750A (en) Prostaglandin analogues,their preparation, and pharmaceutical composit ions containing the same as active ingredient
DE3275083D1 (en) Cycloaliphatic alcohols
DK573487A (en) CYCLODEXTRINCLATHRATES OF CARBACYCLININE DERIVATIVES AND USE THEREOF AS A MEDICINE